1.A comprehensive evaluation of sexual and reproductive outcomes following robot-assisted retroperitoneal lymph node dissection for nonseminomatous germ cell tumor.
Francesco A MISTRETTA ; Ottavio DE COBELLI ; Paolo VERZE ; Francesco BOTTICELLI ; Letizia JANNELLO ; Stefano LUZZAGO ; Gabriele COZZI ; Roberto BIANCHI ; Ettore DI TRAPANI ; Matteo FERRO ; Giovanni CORDIMA ; Danilo BOTTERO ; Deliu Victor MATEI ; Vincenzo MIRONE ; Gennaro MUSI
Asian Journal of Andrology 2022;24(6):579-583
Sexual disorders following retroperitoneal pelvic lymph node dissection (RPLND) for testis tumor can affect the quality of life of patients. The aim of the current study was to investigate several different andrological outcomes, which may be influenced by robot-assisted (RA) RPLND. From January 2012 to March 2020, 32 patients underwent RA-RPLND for stage I nonseminomatous testis cancer or postchemotherapy (PC) residual mass. Modified unilateral RPLND nerve-sparing template was always used. Major variables of interest were erectile dysfunction (ED), premature ejaculation (PE), dry ejaculation (DE), or orgasm alteration. Finally, fertility as well as the fecundation process (sexual intercourse or medically assisted procreation [MAP]) was investigated. Ten patients (31.3%) presented an andrological disorder of any type after RA-RPLND. Hypospermia was present in 4 (12.5%) patients, DE (International Index of Erectile Function-5 [IIEF-5] <25) in 3 (9.4%) patients, and ED in 3 (9.4%) patients. No PE or orgasmic alterations were described. Similar median age at surgery, body mass index (BMI), number of nodes removed, scholar status, and preoperative risk factor rates were identified between groups. Of all these 10 patients, 6 (60.0%) were treated at the beginning of our robotic experience (2012-2016). Of all 32 patients, 5 (15.6%) attempted to have a child after RA-RPLND. All of these 5 patients have successfully fathered children, but 2 (40.0%) required a MAP. In conclusion, a nonnegligible number of andrological complications occurred after RA-RPLND, mainly represented by ejaculation disorders, but ED occurrence and overall sexual satisfaction deficit should be definitely considered. No negative impact on fertility was described after RA-RPLND.
Male
;
Child
;
Humans
;
Robotics
;
Quality of Life
;
Retrospective Studies
;
Neoplasms, Germ Cell and Embryonal/surgery*
;
Testicular Neoplasms/pathology*
;
Lymph Node Excision/adverse effects*
;
Retroperitoneal Space/surgery*
;
Erectile Dysfunction/surgery*
;
Treatment Outcome
2.Epididymal liposarcoma with metastases to the retroperitoneal space and peritoneal cavity: A case report and literature review.
National Journal of Andrology 2017;23(12):1103-1106
Objective:
To report a rare case of epididymal liposarcoma with multiple metastases to the retroperitoneal space and peritoneal cavity for the purpose of improving the diagnosis and treatment of the disease.
METHODS:
We retrospectively analyzed the clinical data about a case of epididymal liposarcoma with multiple metastases to the retroperitoneal space and peritoneal cavity, reviewed relevant literature at home and abroad, and investigated the presentation, diagnosis and treatment of the disease.
RESULTS:
A 47-year-old male patient with epididymal liposarcoma underwent radical left orchiectomy with high ligation of the spermmatic cord. Ten years later, recurrence and metastasis were observed in the retroperitoneal space with a mass of 15.6 × 9.4 × 25.5 cm occupying an area from the upper pole of the left kidney to the pelvic cavity and enclosing the left kidney and upper ureter, for which the patient received radical resection of the retroperitoneal tumor. However, multiple retroperitoneal and intraperitoneal metastases occurred again 4 years later, which was treated by another surgical resection. The patient died of lung failure a year later.
CONCLUSIONS
Epididymal liposarcoma is a rare entity, which can be diagnosed by careful clinical and radiological examinations and confirmed by pathology. For its treatment, radical inguinal orchiectomy should be performed as early as possible, but the roles of adjuvant radiotherapy and chemotherapy remain controversial. Given the high rate of recurrence and metastasis, long-term follow-up is necessitated for the patient postoperatively.
Epididymis
;
pathology
;
Genital Neoplasms, Male
;
pathology
;
Humans
;
Kidney
;
Liposarcoma
;
pathology
;
secondary
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local
;
Orchiectomy
;
Peritoneal Cavity
;
Peritoneal Neoplasms
;
secondary
;
Retroperitoneal Neoplasms
;
secondary
;
Retroperitoneal Space
3.A case of retroperitoneal Castleman's disease with paraneoplastic pemphigus.
Zhipeng ZHANG ; Maosong ZHOU ; Jin GUO ; Tiecheng FENG ; Xinying LI ; Huan CHEN ; Jindong LI
Journal of Central South University(Medical Sciences) 2016;41(5):548-552
Paraneoplastic pemphigus is a rare autoimmune bullous dermatosis, which is caused by potential neoplasm, especially the Castleman's disease. Castleman's disease associated with paraneoplastic pemphigus is misdiagnosed frequently and easily in clinical practices. Furthermore, it is reported that the mortality rate for this disease is very high. Bronchiolitis obliterans is the most common complication and the most important cause of death. There was a female patient presenting recalcitrant mucocutaneous erosions, ulcers and scattered erythemas in the body. The patient was diagnosed and treated for pemphigus vulgaris with little success in Xiangya Hospital, Central South University in January 2015. Further investigations confirmed the diagnosis of paraneoplastic pemphigus with retroperitoneal tumor. Subsequently, the patient was treated with tumor resection in combination with intravenous immunoglobulin and corticosteroids. The pathology revealed that it was the Castleman's disease. Her mucocutaneous performance recovered obviously and the bronchiolitis obliteran did not appear in the follow-up. Castleman's disease associated with paraneoplastic pemphigus should be considered when mucosal and skin lesions showing no improvement under corticosteroids. Early and complete removal of the tumor together with immunotherapy could be beneficial to the patient's prognosis.
Adrenal Cortex Hormones
;
therapeutic use
;
Castleman Disease
;
complications
;
therapy
;
Female
;
Humans
;
Immunoglobulins, Intravenous
;
therapeutic use
;
Paraneoplastic Syndromes
;
complications
;
therapy
;
Pemphigus
;
complications
;
therapy
;
Retroperitoneal Space
;
pathology
4.CT and MR findings of retroperitoneal ectopic pheochromocytoma.
Zheng ZHU ; Xinming ZHAO ; Email: XINMINGZH@SINA.COM. ; Jingrui DAI ; Chunwu ZHOU
Chinese Journal of Oncology 2015;37(3):181-185
OBJECTIVETo evaluate the CT and MR findings of retroperitoneal ectopic pheochromocytoma.
METHODSTo analyze retrospectively the CT and MR images of 32 patients with retroperitoneal ectopic pheochromocytoma proved by pathology.
RESULTSThe lesions (benign=28, malignant=4) were located in the anterior pararenal space (ARS) (n=12), the perirenal space (PS) (n=13) and the posterior pararenal space (PRS) (n=7). The tumors showed heterogeneous density on unenhanced CT (n=25). Among the 23 cases with enhanced CT imaging, 19 cases had marked contrast and 4 had mild contrast. The enhancement patterns included whole enhancement (n=9), solid area enhancement (n=12), peripheral enhancement (n=1), and spotted enhancement (n=1). The tumors had heterogeneous signal on unenhanced MR (n=23), and usually showed enhancement at arterial, portal and delayed phases on 22 enhanced MR, while cystic area with no enhancement. The lesions usually had cystic changes (n=18), septa (n=16), vessels inside (n=9), hemorrhage (n=3), and calcification (n=3). Besides that the morphology had statistical significance (P=0.013), other indexes had no statistical significance (P>0.05) in differential diagnosis of benign and malignant retroperitoneal ectopic pheochromocytomas.
CONCLUSIONSRetroperitoneal ectopic pheochromocytomas have some CT and MR features, usually revealed as an oval mass, growing along the paravertebral axis, and often with cystic changes. Those signs combined with hypertension and elevated catecholamine level may lead to a correct diagnosis.
Adrenal Gland Neoplasms ; diagnostic imaging ; pathology ; Calcinosis ; Diagnosis, Differential ; Humans ; Hypertension ; Image Enhancement ; Pheochromocytoma ; diagnostic imaging ; pathology ; Retroperitoneal Space ; Retrospective Studies ; Tomography, X-Ray Computed
5.Analysis of clinical features of retroperitoneal bronchogenic cyst.
Houfeng HUANG ; Guanghua LIU ; Hanzhong LI ; Weigang YAN ; Yushi ZHANG ; Zhigang JI ; Email: JZHGPUMCH@163.COM.
Chinese Journal of Surgery 2015;53(11):856-859
OBJECTIVETo analyze the clinical features of retroperitoneal bronchogenic cyst.
METHODSThe clinical data of 6 cases with retroperitoneal brochogenic cyst treated in Peking Union Medical College Hospital from April 1996 to October 2014 were retrospectively analyzed. The clinical manifestation, diagnosis, treatment and prognosis were analyzed.
RESULTSOf the patients, 1 was male and 5 were female aging from 31 to 50 years with a mean age of 38.3 years. Three cases were diagnosed from physical examination, 2 cases from upper abdominal pain and 1 case from left flank pain. The cysts located in the left adrenal region, between the liver and the pancreas, and anterior aspect of the tail of the pancreas were seen in 4 cases, 1 case and 1 case, respectively. The major diameter was from 5 cm to 13 cm, and the mean major diameter was 7 cm. Ultrasonography and CT scan could reveal cystic, cystic-solid or solid masses. Color doppler flow imaging showed no obvious blood flow, and contrast-enhanced CT scans showed no enhancement or no obvious enhancement. Six cases were all misdiagnosed preoperatively. They all underwent operations via retroperitoneal laparoscopic resection for 3 cases, laparotomy for 2 cases and open flank resection for 1 case respectively. The pathological diagnoses were all bronchogenic cysts. Three symptomatic patients became asymptomatic after operations. Five patients had been followed up. During the follow-up of 2 months to 15 years, no recurrence had been found with CT scan.
CONCLUSIONSRetroperitoneal bronchogenic cyst is rare and easily misdiagnosed. It should be considered in the differential diagnosis of a retroperitoneal mass. Most cysts are positioned in the left adrenal region and adjacent regions. Some cysts demonstrate soft tissue characteristics in image. After surgical removal, the patients have a good prognosis.
Adult ; Bronchogenic Cyst ; diagnosis ; pathology ; Diagnosis, Differential ; Female ; Humans ; Laparoscopy ; Laparotomy ; Liver ; pathology ; Male ; Middle Aged ; Pancreas ; pathology ; Prognosis ; Retroperitoneal Space ; pathology ; Retrospective Studies ; Tomography, X-Ray Computed
6.CT imaging features for 2 cases of retroperitoneal solitary fibrous tumor.
Fei TANG ; Hui LIU ; Shunke ZHOU ; Jun LIU ; Sainan CAI ; Manjun XIAO ; Xin SU
Journal of Central South University(Medical Sciences) 2015;40(8):941-944
OBJECTIVE:
To determine the CT imaging features for retroperitoneal solitary fibrous tumor (SFT).
METHODS:
The imaging features of CT for 2 SFT cases, confirmed by pathological examination, were retrospectively analyzed and compared with pathological results.
RESULTS:
The results of CT showed that retroperitoneal SFTs were large, well-defined and consisted of solid components with different density (equal or low). In the scan of contrast enhancement, tumors were strongly enhanced, and the multiple vascular shadows were seen in the tumor at arterial phase. There was progressive enhancement from the arterial to venous phase, and capsule of tumor was displayed. Histologically, the tumors were composed of spindle cells within a background of collagen stroma, and showed a wide range of growth patterns, alternating hypercellular (tumor cell-rich) and hypocellular (collagen-rich) areas. The diagnosis was confirmed by positive immunohistochemical staining for CD34 and bcl-2.
CONCLUSION
The retroperitoneal SFT possesses a definite characteristic in CT imaging features, and the diagnosis can be confirmed by histopathology and immunohistochemistry.
Humans
;
Hyperplasia
;
Immunohistochemistry
;
Retroperitoneal Space
;
pathology
;
Retrospective Studies
;
Solitary Fibrous Tumors
;
diagnosis
;
Tomography, X-Ray Computed
7.Clinical analysis of 53 cases of retroperitoneal schwannoma.
Haitao ZHOU ; Zhixiang ZHOU ; Jianwei LIANG ; Zheng WANG ; Xingmao ZHANG ; Junjie HU ; Hong ZHAO ; Yi FANG ; Zhen HUANG ; Jian WANG ; Weigen ZENG
Chinese Journal of Oncology 2014;36(11):867-870
OBJECTIVETo explore the clinical characteristics, diagnosis and treatment regimens for retroperitoneal schwannoma.
METHODSClinicopathological data of 53 retroperitoneal schwannoma patients treated from January 1999 to April 2013 in our hospital were collected and analyzed using SPSS 13.0 statistical software.
RESULTSSymptoms of the retroperitoneal schwannoma were vague and nonspecific. 12 patients had interrupted abdominal pain, 9 patients had abdominal discomfort, and only 6 patients presented with abdominal mass while 24 patients were detected by health checkup. There were some characteristics but not specific findings in imaging examination such as CT, ultrasonography and MRI, so preoperative diagnosis rate was low with only 9 patients diagnosed as retroperitoneal schwannoma and 21 patients diagnosed as neurogenic tumor. S-100 immunohistochemisty was very important in pathological diagnosis, and the patients with benign retroperitoneal schwannoma got 100% tumor specific 5-year survival after complete excision while the 5-year survival of malignant retroperitoneal schwannoma was only 50.0%.
CONCLUSIONSRetroperitoneal schwannoma is a rare disease. Most of them are benign tumors, and complete surgical excision is the effective treatment.
Abdominal Pain ; Diagnostic Imaging ; Humans ; Magnetic Resonance Imaging ; Neurilemmoma ; diagnosis ; pathology ; therapy ; Physical Examination ; Retroperitoneal Neoplasms ; diagnosis ; pathology ; therapy ; Retroperitoneal Space ; Treatment Outcome
8.CT and MRI Features and pathological characteristics of retroperitoneal localized Castleman's disease.
Chun WANG ; Jianjun ZHOU ; Zhoupeng MA ; Shunzhuang ZHANG ; Xudao MAO ; Penggen QIU ; Huaying TENG
Chinese Journal of Oncology 2014;36(3):193-197
OBJECTIVETo analyze the CT and MRI findings and pathological characteristics of retroperitoneal localized Castleman's disease and discuss the diagnostic and differential value of CT and MRI.
METHODSCT, MRI and clinical data of retroperitoneal localized Castleman's disease, proved by surgery and pathology, of 13 patients were reviewed. Among them, all the 13 cases received CT, and 4 cases received MRI examination.
RESULTSAmong the 13 cases, 12 cases were of hyaline vascular type, and one was of mixed type. All foci were single mass and most foci located in the periphery of the kidney. The maximum diameter was 4.2 cm to 8.6 cm and the mean diameter of all tumors was 5.9 cm. The outline of most tumors was clear and kidney-shaped. On unenhanced CT, 10 cases showed low density and 3 cases showed isodensity. On plain MRI, four cases showed iso-signal on T1WI, three cases showed slightly high signal on T2WI and one showed moderately high signal. The CT and MRI findings were similar on contrast enhanced scan. In arterial phase, 10 cases showed moderate enhancement, 2 cases showed significant enhancement and one case showed moderate enhancement. Five cases showed rather homogeneous enhancement and 8 cases showed heterogeneous enhancement.In venous phase, all the 13 tumors showed continuous enhancement. Eight cases showing heterogeneous enhancement in arterial phase showed expanded range, and among them two cases showed tending to be homogeneous enhancement. Six cases showed areas of low density without enhancement, and 9 cases were accompanied with single or multi-satellite punctuate or striped foci around the tumors.
CONCLUSIONDynamic contrast-enhanced CT and MRI combined with MR T2WI fat-suppression are of great importance in the diagnosis and identification of retroperitoneal localized Castleman's disease.
Adult ; Castleman Disease ; diagnostic imaging ; pathology ; surgery ; Female ; Humans ; Image Enhancement ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Radiographic Image Enhancement ; Retroperitoneal Space ; diagnostic imaging ; Retrospective Studies ; Tomography, X-Ray Computed
9.Retroperitoneal schwannoma mimicking metastatic seminoma: case report and literature review.
Shi-Qiang ZHANG ; Song WU ; Kai YAO ; Pei DONG ; Yong-Hong LI ; Zhi-Ling ZHANG ; Xian-Xin LI ; Fang-Jian ZHOU
Chinese Journal of Cancer 2013;32(3):149-152
If a testicular cancer patient has a mass in the retroperitoneum, a metastasis is often the first suspicion, probably leading to improper diagnosis and overtreatment. Here we report a case of retroperitoneal schwannoma mimicking metastatic seminoma. A 29-year-old man, who had a history of seminoma, presented with a single retroperitoneal mass suspected to be a metastasis. Because the patient refused radiotherapy, 3 cycles of cisplatin, etoposide, and bleomycin were offered. Post-chemotherapy computed tomography scan revealed persistence of the retroperitoneal mass, with no change in tumor size or characteristics. Subsequently, retroperitoneal lymph node dissection was performed. The dissected tissue contained negative lymph nodes but a single mass in the attached fat. Pathology revealed retroperitoneal schwannoma, which was confirmed by immunohistochemistry. Thus, clinicians should be aware of retroperitoneal schwannoma and its distinction from metastatic seminoma to avoid misdiagnosis and ensure proper treatment.
Adult
;
Antibiotics, Antineoplastic
;
therapeutic use
;
Antineoplastic Agents
;
therapeutic use
;
Antineoplastic Agents, Phytogenic
;
therapeutic use
;
Bleomycin
;
therapeutic use
;
Cisplatin
;
therapeutic use
;
Diagnostic Errors
;
Etoposide
;
therapeutic use
;
Humans
;
Lymph Node Excision
;
Lymph Nodes
;
pathology
;
Lymphatic Metastasis
;
Male
;
Neoplasms, Multiple Primary
;
Neurilemmoma
;
diagnostic imaging
;
drug therapy
;
pathology
;
Radiography
;
Retroperitoneal Neoplasms
;
diagnostic imaging
;
drug therapy
;
pathology
;
secondary
;
Retroperitoneal Space
;
Seminoma
;
secondary
;
surgery
;
Testicular Neoplasms
;
surgery
10.Modified Retroperitoneal Access for Percutaneous Intervention after Pancreaticoduodenectomy.
Korean Journal of Radiology 2013;14(3):446-450
Percutaneous access to the surgical bed after pancreaticoduodenectomy can be a challenge, due to the post-operative anatomy alteration. However, immediate complications, such as surgical bed abscess or suspected tumor recurrence, are often best accessed percutaneously, as open surgical or endoscopic approaches are often difficult, if not impossible. We, hereby, describe a safe approach that is highly replicable, in accessing the surgical bed for percutaneous intervention, following pancreaticoduodenectomy.
Abscess/radiography/therapy
;
Bile Duct Neoplasms/pathology/radiography
;
Biopsy/methods
;
Catheterization/*methods
;
Cholangiocarcinoma/pathology/radiography
;
Drainage/instrumentation/*methods
;
Humans
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local/pathology/radiography
;
Pancreatic Diseases/radiography/therapy
;
*Pancreaticoduodenectomy
;
Postoperative Complications/radiography/*therapy
;
Radiography, Interventional/methods
;
Retroperitoneal Space

Result Analysis
Print
Save
E-mail